×
About 141,486 results

ALLMedicine™ Kidney Disease Center

Research & Reviews  66,873 results

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systemati...
https://doi.org/10.1186/s12933-021-01293-8 10.1016/S0140-6736(11)61514-6 10.1016/j.jacc.2019.07.020 10.1161/CIRCULATIONAHA.108.821306 10.1016/j.jacc.2019.08.1031 10.1186/s12933-019-0983-1 10.3389/fphys.2018.01669 10.1161/01.CIR.0000072767.89944.6E 10.1161/01.CIR.84.1.40 10.1093/europace/euv191 10.1016/S0735-1097(00)00982-7 10.1067/mhj.2002.121264 10.1186/s12933-018-0779-8 10.1016/j.jacc.2018.06.040 10.1161/JAHA.119.014908 10.1186/s12933-019-0916-z 10.1016/j.jash.2014.01.007 10.1161/CIRCULATIONAHA.119.044183 10.1177/2047487318755531 10.1002/ejhf.1663 10.1186/s12933-020-01048-x 10.1186/s12933-021-01243-4 10.1111/dom.13077 10.1136/bmj.n71 10.1093/ehjcvp/pvaa065 10.1136/bmj.d5928 10.1136/bmj.39489.470347.AD 10.1186/1741-7015-11-43 10.1111/dme.12624 10.1111/dom.12428 10.1111/ijcp.12322 10.1056/NEJMoa1611925 10.2337/dc14-0315 10.1056/NEJMoa1812389 10.1161/CIRCULATIONAHA.119.042375 10.1056/NEJMoa1504720 10.1111/dom.12149 10.1111/jgs.12881 10.1111/dom.12503 10.1016/j.clinthera.2015.05.511 10.2337/dc15-0779 10.2337/dc16-1347 10.7326/0003-4819-156-6-201203200-00003 10.1111/dom.12348 10.1016/S2213-8587(13)70208-0 10.1007/s13300-017-0337-5 10.1056/NEJMoa1811744 10.1002/ejhf.1713 10.1056/NEJMoa1911303 10.1016/S0140-6736(18)32590-X 10.1186/s12933-019-0919-9 10.1111/dom.13295 10.1080/20009666.2018.1514932 10.1186/s12933-020-01105-5 10.1016/j.jacc.2020.05.037 10.1186/s12933-020-01127-z 10.1186/s12933-020-01043-2 10.1186/s12933-020-01180-8 10.1007/s00204-015-1477-x 10.14740/jocmr3011w 10.1016/j.jjcc.2017.12.004 10.1161/JAHA.120.018889 10.1371/journal.pone.0235640 10.1177/1479164120971220 10.1001/jamacardio.2017.2275 10.1093/cvr/cvx149 10.1186/s12933-019-0984-0 10.1186/s12933-019-0964-4 10.2337/db15-1356 10.2337/dc16-0330 10.1161/CIRCEP.108.817320
Cardiovascular Diabetology; Li HL, Lip GH et. al.

May 8th, 2021 - Cardiac arrhythmias are associated with poorer outcomes in patients with heart failure (HF), diabetes mellitus (DM), and chronic kidney disease (CKD). Previous studies have shown inconsistent conclusions regarding the association between sodium-gl...

Effect of the Phosphate Binders Sevelamer Carbonate and Calcium Acetate on the Pharmaco...
https://doi.org/10.1016/j.clinthera.2021.03.025
Clinical Therapeutics; Groenendaal-van de Meent D, Kerbusch V et. al.

May 8th, 2021 - Roxadustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor, treats anemia in chronic kidney disease. Hyperphosphatemia, a common complication in chronic kidney disease, is treated with phosphate binders (PBs). This study in healthy indivi...

Post-Liver Transplant Acute Kidney Injury.
https://doi.org/10.1002/lt.26094
Liver Transplantation : Official Publication of the Ameri... Dong V, Nadim MK et. al.

May 8th, 2021 - Acute kidney injury (AKI) is a common condition following liver transplantation (LT). It negatively impacts patient outcomes by increasing the chances of developing chronic kidney disease (CKD) and reducing graft and patient survival. Multiple def...

see more →

Guidelines  315 results

ACR Appropriateness Criteria® Renal Failure.
https://doi.org/10.1016/j.jacr.2021.02.019
Journal of the American College of Radiology : JACR; , Wong-You-Cheong JJ et. al.

May 7th, 2021 - Renal failure can be divided into acute kidney injury and chronic kidney disease. Both are common and result in increased patient morbidity and mortality. The etiology is multifactorial and differentiation of acute kidney injury from chronic kidne...

Central and Peripheral Arterial Diseases in Chronic Kidney Disease: Conclusions from a ...
https://doi.org/10.1016/j.kint.2021.04.029
Kidney International; Johansen KL, Garimella PS et. al.

May 7th, 2021 - Chronic kidney disease (CKD) affects about 10% of all populations worldwide, with about 2 million people requiring dialysis. Although patients with CKD are at high risk of cardiovascular disease (CVD) and events, they are often underrepresented or...

Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation R...
https://doi.org/10.1001/jama.2021.4987
JAMA , Krist AH et. al.

Apr 27th, 2021 - Hypertension is a prevalent condition that affects approximately 45% of the adult US population and is the most commonly diagnosed condition at outpatient office visits. Hypertension is a major contributing risk factor for heart failure, myocardia...

Controversies in optimal anemia management: conclusions from a Kidney Disease: Improvin...
https://doi.org/10.1016/j.kint.2021.03.020
Kidney International; Babitt JL, Eisenga MF et. al.

Apr 11th, 2021 - In chronic kidney disease, anemia and disordered iron homeostasis are prevalent and associated with significant adverse consequences. In 2012, Kidney Disease: Improving Global Outcomes (KDIGO) issued an anemia guideline for managing the diagnosis,...

2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for ...
https://doi.org/10.1016/j.cjca.2021.03.016
The Canadian Journal of Cardiology; Pearson GJ, Thanassoulis G et. al.

Mar 30th, 2021 - The 2021 guidelines primary panel selected clinically relevant questions and produced updated recommendations, on the basis of important new findings emerging since the 2016 guidelines. In subjects with clinical atherosclerosis, abdominal aortic a...

see more →

Drugs  379 results see all →

Clinicaltrials.gov  70,185 results

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systemati...
https://doi.org/10.1186/s12933-021-01293-8 10.1016/S0140-6736(11)61514-6 10.1016/j.jacc.2019.07.020 10.1161/CIRCULATIONAHA.108.821306 10.1016/j.jacc.2019.08.1031 10.1186/s12933-019-0983-1 10.3389/fphys.2018.01669 10.1161/01.CIR.0000072767.89944.6E 10.1161/01.CIR.84.1.40 10.1093/europace/euv191 10.1016/S0735-1097(00)00982-7 10.1067/mhj.2002.121264 10.1186/s12933-018-0779-8 10.1016/j.jacc.2018.06.040 10.1161/JAHA.119.014908 10.1186/s12933-019-0916-z 10.1016/j.jash.2014.01.007 10.1161/CIRCULATIONAHA.119.044183 10.1177/2047487318755531 10.1002/ejhf.1663 10.1186/s12933-020-01048-x 10.1186/s12933-021-01243-4 10.1111/dom.13077 10.1136/bmj.n71 10.1093/ehjcvp/pvaa065 10.1136/bmj.d5928 10.1136/bmj.39489.470347.AD 10.1186/1741-7015-11-43 10.1111/dme.12624 10.1111/dom.12428 10.1111/ijcp.12322 10.1056/NEJMoa1611925 10.2337/dc14-0315 10.1056/NEJMoa1812389 10.1161/CIRCULATIONAHA.119.042375 10.1056/NEJMoa1504720 10.1111/dom.12149 10.1111/jgs.12881 10.1111/dom.12503 10.1016/j.clinthera.2015.05.511 10.2337/dc15-0779 10.2337/dc16-1347 10.7326/0003-4819-156-6-201203200-00003 10.1111/dom.12348 10.1016/S2213-8587(13)70208-0 10.1007/s13300-017-0337-5 10.1056/NEJMoa1811744 10.1002/ejhf.1713 10.1056/NEJMoa1911303 10.1016/S0140-6736(18)32590-X 10.1186/s12933-019-0919-9 10.1111/dom.13295 10.1080/20009666.2018.1514932 10.1186/s12933-020-01105-5 10.1016/j.jacc.2020.05.037 10.1186/s12933-020-01127-z 10.1186/s12933-020-01043-2 10.1186/s12933-020-01180-8 10.1007/s00204-015-1477-x 10.14740/jocmr3011w 10.1016/j.jjcc.2017.12.004 10.1161/JAHA.120.018889 10.1371/journal.pone.0235640 10.1177/1479164120971220 10.1001/jamacardio.2017.2275 10.1093/cvr/cvx149 10.1186/s12933-019-0984-0 10.1186/s12933-019-0964-4 10.2337/db15-1356 10.2337/dc16-0330 10.1161/CIRCEP.108.817320
Cardiovascular Diabetology; Li HL, Lip GH et. al.

May 8th, 2021 - Cardiac arrhythmias are associated with poorer outcomes in patients with heart failure (HF), diabetes mellitus (DM), and chronic kidney disease (CKD). Previous studies have shown inconsistent conclusions regarding the association between sodium-gl...

Effect of the Phosphate Binders Sevelamer Carbonate and Calcium Acetate on the Pharmaco...
https://doi.org/10.1016/j.clinthera.2021.03.025
Clinical Therapeutics; Groenendaal-van de Meent D, Kerbusch V et. al.

May 8th, 2021 - Roxadustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor, treats anemia in chronic kidney disease. Hyperphosphatemia, a common complication in chronic kidney disease, is treated with phosphate binders (PBs). This study in healthy indivi...

Post-Liver Transplant Acute Kidney Injury.
https://doi.org/10.1002/lt.26094
Liver Transplantation : Official Publication of the Ameri... Dong V, Nadim MK et. al.

May 8th, 2021 - Acute kidney injury (AKI) is a common condition following liver transplantation (LT). It negatively impacts patient outcomes by increasing the chances of developing chronic kidney disease (CKD) and reducing graft and patient survival. Multiple def...

see more →

News  3,607 results

Is Potentially Inappropriate Prescribing Common in Chronic Kidney Disease?
https://www.medscape.com/viewarticle/950620

May 5th, 2021 - Potentially inappropriate prescribing is common in patients with chronic kidney disease (CKD) in primary care, according to a new retrospective Scottish population-based analysis. High-risk prescribing in CKD contributes to adverse drug reactions ...

Elevated Albumin-Creatinine Ratio and Reduced eGFR Tied to CKD Progression
https://www.medscape.com/viewarticle/950330

May 2nd, 2021 - Takeaway The combination of increased urinary albumin-creatinine ratio (UACR) and decreased estimated glomerular filtration rate (eGFR) was strongly associated with an increased risk of advanced chronic kidney disease (CKD) and kidney failure. Why...

FDA Approves Dapagliflozin (Farxiga) for Chronic Kidney Disease
https://www.medscape.com/viewarticle/950329

Apr 29th, 2021 - The US Food and Drug Administration (FDA) has approved dapagliflozin (Farxiga, AstraZeneca) to reduce the risk for kidney function decline, kidney failure, cardiovascular death, and hospitalization for heart failure in adult patients with chronic ...

Older, Sicker Diabetes Patients Have Worse COVID-19 Prognosis
https://www.medscape.com/viewarticle/950135

Apr 27th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A large meta-analysis of patients with COVID-19 and diabetes "provides the best current evidence" to identify the risk for severe COVID-19 or deat...

Vadadustat for Anemia in Chronic Kidney Disease: Questions Remain
https://www.medscape.com/viewarticle/950130

Apr 27th, 2021 - Oral vadadustat, one of a new class of hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs), is effective in the treatment of anemia in people with chronic kidney disease (CKD), but cardiovascular safety outcomes fall short of convent...

see more →

Patient Education  127 results see all →